Quality of life and utility decrement associated with Clostridium difficile infection in a French hospital setting-Reference-Cited by-同舟云学术

Quality of life and utility decrement associated with Clostridium difficile infection in a French hospital setting

Published:2019-01-11 Issue:1 Volume:17 Page:
ISSN:1477-7525
Container-title:Health and Quality of Life Outcomes
language:en
Short-container-title:Health Qual Life Outcomes

Author:

Barbut Frédéric,Galperine Tatiana,Vanhems Philippe,Le Monnier Alban,Durand-Gasselin Bernard,Canis Frédérique,Jeanbat Viviane,Duburcq Anne,Alami Sarah,Bensoussan Caroline,Fagnani Francis

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12955-019-1081-5.pdf

Reference39 articles.

1. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009;7:52–36.

2. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46:S12–8.

3. Lessa FC, Winston LG, McDonald LC, Emerging Infections Program C. difficile Surveillance Team. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:2369–70.

4. Wiegand PN, Nathwani D, Wilcox MH, Stephens J, Shelbaya A, Haider S. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility acquired infection. J Hosp Infect. 2012;81:1–14.

5. Schmid D, Kuo HW, Simons E, Kanitz EE, Wenisch J, Allerberger F, et al. All-cause mortality in hospitalized patients with infectious diarrhea: Clostridium difficile versus other enteric pathogens in Austria from 2008 to 2010. J Infect Public Health. 2014;7:133–44.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking the Cycle of Recurrent Clostridioides difficile Infections: A Narrative Review Exploring Current and Novel Therapeutic Strategies;Journal of Pharmacy Practice;2024-05-13

2. Epidemiological and clinical burden of Clostridioides difficile infections and recurrences between 2015 − 2019: the RECUR Germany study;BMC Infectious Diseases;2024-03-27

3. Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study;International Journal of Infectious Diseases;2024-03

4. Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States;Value in Health;2024-02

5. Impact on Quality of Life by <i>Clostridioides difficile</i> Infections among Hospitalized Patients in Japan;Kansenshogaku Zasshi;2024-01-20